221 related articles for article (PubMed ID: 33242457)
1. Pharmacokinetics and safety of early nevirapine-based antiretroviral therapy for neonates at high risk for perinatal HIV infection: a phase 1/2 proof of concept study.
Ruel TD; Capparelli EV; Tierney C; Nelson BS; Coletti A; Bryson Y; Cotton MF; Spector SA; Mirochnick M; LeBlanc R; Reding C; Zimmer B; Persaud D; Bwakura-Dangarembizi M; Naidoo KL; Hazra R; Jean-Philippe P; Chadwick EG
Lancet HIV; 2021 Mar; 8(3):e149-e157. PubMed ID: 33242457
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 reservoir size after neonatal antiretroviral therapy and the potential to evaluate antiretroviral-therapy-free remission (IMPAACT P1115): a phase 1/2 proof-of-concept study.
Persaud D; Bryson Y; Nelson BS; Tierney C; Cotton MF; Coletti A; Jao J; Spector SA; Mirochnick M; Capparelli EV; Costello D; Szewczyk J; Nicodimus N; Stranix-Chibanda L; Kekitiinwa AR; Korutaro V; Reding C; Carrington MN; Majji S; Yin DE; Jean-Philippe P; Chadwick EG
Lancet HIV; 2024 Jan; 11(1):e20-e30. PubMed ID: 38061376
[TBL] [Abstract][Full Text] [Related]
3. A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006).
Musoke P; Guay LA; Bagenda D; Mirochnick M; Nakabiito C; Fleming T; Elliott T; Horton S; Dransfield K; Pav JW; Murarka A; Allen M; Fowler MG; Mofenson L; Hom D; Mmiro F; Jackson JB
AIDS; 1999 Mar; 13(4):479-86. PubMed ID: 10197376
[TBL] [Abstract][Full Text] [Related]
4. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
; de Vincenzi I
Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial.
Lockman S; Brummel SS; Ziemba L; Stranix-Chibanda L; McCarthy K; Coletti A; Jean-Philippe P; Johnston B; Krotje C; Fairlie L; Hoffman RM; Sax PE; Moyo S; Chakhtoura N; Stringer JS; Masheto G; Korutaro V; Cassim H; Mmbaga BT; João E; Hanley S; Purdue L; Holmes LB; Momper JD; Shapiro RL; Thoofer NK; Rooney JF; Frenkel LM; Amico KR; Chinula L; Currier J;
Lancet; 2021 Apr; 397(10281):1276-1292. PubMed ID: 33812487
[TBL] [Abstract][Full Text] [Related]
6. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
[TBL] [Abstract][Full Text] [Related]
7. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
[TBL] [Abstract][Full Text] [Related]
8. Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial.
Dorenbaum A; Cunningham CK; Gelber RD; Culnane M; Mofenson L; Britto P; Rekacewicz C; Newell ML; Delfraissy JF; Cunningham-Schrader B; Mirochnick M; Sullivan JL;
JAMA; 2002 Jul; 288(2):189-98. PubMed ID: 12095383
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Pediatric AIDS Clinical Trials Group Protocol 250 Team.
Mirochnick M; Fenton T; Gagnier P; Pav J; Gwynne M; Siminski S; Sperling RS; Beckerman K; Jimenez E; Yogev R; Spector SA; Sullivan JL
J Infect Dis; 1998 Aug; 178(2):368-74. PubMed ID: 9697716
[TBL] [Abstract][Full Text] [Related]
10. Treating HIV during pregnancy: an update on safety issues.
Watts DH
Drug Saf; 2006; 29(6):467-90. PubMed ID: 16752931
[TBL] [Abstract][Full Text] [Related]
11. Nevirapine Pharmacokinetics and Safety in Neonates Receiving Combination Antiretroviral Therapy for Prevention of Vertical HIV Transmission.
Lau E; Brophy J; Samson L; Kakkar F; Campbell DM; Yudin MH; Murphy K; Seto W; Colantonio D; Read SE; Bitnun A
J Acquir Immune Defic Syndr; 2017 Apr; 74(5):493-498. PubMed ID: 28114187
[TBL] [Abstract][Full Text] [Related]
12. Nevirapine: a review of its use in the prevention and treatment of paediatric HIV infection.
Bardsley-Elliot A; Perry CM
Paediatr Drugs; 2000; 2(5):373-407. PubMed ID: 11022799
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Nevirapine Prophylactic and Therapeutic Dosing Regimens for Neonates.
Cressey TR; Punyawudho B; Le Coeur S; Jourdain G; Saenjum C; Capparelli EV; Jittayanun K; Phanomcheong S; Luvira A; Borkird T; Puangsombat A; Aarons L; Sukrakanchana PO; Urien S; Lallemant M;
J Acquir Immune Defic Syndr; 2017 Aug; 75(5):554-560. PubMed ID: 28489732
[TBL] [Abstract][Full Text] [Related]
14. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Brocklehurst P; Volmink J
Cochrane Database Syst Rev; 2002; (2):CD003510. PubMed ID: 12076484
[TBL] [Abstract][Full Text] [Related]
15. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Brocklehurst P; Volmink J
Cochrane Database Syst Rev; 2002; (1):CD003510. PubMed ID: 11869666
[TBL] [Abstract][Full Text] [Related]
16. Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials.
; Bedri A; Gudetta B; Isehak A; Kumbi S; Lulseged S; Mengistu Y; Bhore AV; Bhosale R; Varadhrajan V; Gupte N; Sastry J; Suryavanshi N; Tripathy S; Mmiro F; Mubiru M; Onyango C; Taylor A; Musoke P; Nakabiito C; Abashawl A; Adamu R; Antelman G; Bollinger RC; Bright P; Chaudhary MA; Coberly J; Guay L; Fowler MG; Gupta A; Hassen E; Jackson JB; Moulton LH; Nayak U; Omer SB; Propper L; Ram M; Rexroad V; Ruff AJ; Shankar A; Zwerski S
Lancet; 2008 Jul; 372(9635):300-13. PubMed ID: 18657709
[TBL] [Abstract][Full Text] [Related]
17. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial.
Guay LA; Musoke P; Fleming T; Bagenda D; Allen M; Nakabiito C; Sherman J; Bakaki P; Ducar C; Deseyve M; Emel L; Mirochnick M; Fowler MG; Mofenson L; Miotti P; Dransfield K; Bray D; Mmiro F; Jackson JB
Lancet; 1999 Sep; 354(9181):795-802. PubMed ID: 10485720
[TBL] [Abstract][Full Text] [Related]
18. Antiretroviral interventions for preventing breast milk transmission of HIV.
White AB; Mirjahangir JF; Horvath H; Anglemyer A; Read JS
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD011323. PubMed ID: 25280769
[TBL] [Abstract][Full Text] [Related]
19. Efavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals.
Mbuagbaw L; Mursleen S; Irlam JH; Spaulding AB; Rutherford GW; Siegfried N
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD004246. PubMed ID: 27943261
[TBL] [Abstract][Full Text] [Related]
20. Nevirapine: pharmacokinetic considerations in children and pregnant women.
Mirochnick M; Clarke DF; Dorenbaum A
Clin Pharmacokinet; 2000 Oct; 39(4):281-93. PubMed ID: 11069214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
